COVID-19 symptoms that don’t go away affect hundreds of millions worldwide. Scripps Research is recruiting people with long ...

CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.

Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, ...

Cardiovascular disease still claims more lives than any other illness, and many adults living with obesity or type 2 diabetes carry a heavy risk of heart attack and stroke. Two medications, ...

More than 90% of women with polycystic ovary syndrome achieved at least 10% total weight loss after 10 months of tirzepatide ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

Tirzepatide was linked to improved weight loss outcomes in patients with PCOS, especially those who used a digital weight ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company's ...

One big reason Lilly stock has potential is Medicare, the government-run health insurance program for seniors that is the single largest healthcare payer in the U.S.